Alana Rojewski, Ph.D.
Cancer control, namely, tobacco treatment interventions for populations with medical comorbidities and implementing tobacco treatment interventions in the healthcare system
Research Interest
I am an experimental psychologist with a focus in tobacco treatment research and cancer control, and have been actively involved in tobacco treatment research for nearly 15 years. My research goals are to develop tobacco treatment interventions for people who smoke with comorbid conditions (e.g., HIV, cancer) and to implement tobacco treatment interventions in the healthcare setting. I am currently an Assistant Professor in the Department of Public Health Sciences at the Medical University of South Carolina (MUSC) and Member of Hollings Cancer Center (HCC). In addition to my program of research, I am also a Tobacco Treatment Specialist and the Associate Director of the MUSC Health Tobacco Treatment Program. I was awarded a National Cancer Institute (NCI) K07 in September 2017 to pursue training in tobacco treatment and cancer prevention and control and expand my training in implementation and health services research (K07CA214839). My K07 research project is an evaluation of a gain-framed text messaging intervention that is tailored to lung cancer screening patients. I am currently the PI of an NCI R01 to conduct a type 1 effectiveness-implementation trial to evaluate a novel approach to optimizing tobacco treatment delivery for people with HIV who smoke (R01CA261232). Further, I recently received an internal award from the MUSC Institute of Healthy Aging to assess the relationship between age, healthy aging variables, and tobacco treatment outcomes among my R01 study population (people with HIV who smoke). I am also currently a Co-I on 2 NCI R01s: 1) evaluating NRT sampling and gain- framed print materials and videos to promote smoking cessation in lung cancer screening patients (R01CA207229; PI: B. Toll), and 2) evaluating a contingency management intervention for cancer patients undergoing surgery for their cancer (R01CA251158; PI: B. Toll).